Columbia Financial IncAnalyst downbeat forecast with flat net interest income and low margin, price target implies 9% decline.
Wall Street has issued rare downbeat forecasts for Integra LifeSciences, Hamilton Insurance Group, and Columbia Financial. Integra LifeSciences faces declining organic revenue and a high net-debt-to-EBITDA ratio of 5×, with a consensus price target of $17.43 implying a 7.3% downside. Hamilton Insurance Group sees flat sales projections and earnings per share growth trailing revenue gains, trading at 1.1× forward P/B with a $34.14 target. Columbia Financial struggles with flat net interest income and a low 2.1% net interest margin, with a $19 target suggesting a 9% decline from its $20.87 price.
Columbia Financial IncAnalyst downbeat forecast with flat net interest income and low margin, price target implies 9% decline.
Hamilton Insurance Group, Ltd.Analyst downbeat forecast with flat sales and EPS growth trailing revenue, price target implies downside.
Integra LifeSciences HoldingsAnalyst downbeat forecast with declining organic revenue and high leverage, price target implies 7.3% downside.